Literature DB >> 34341167

Pathway-Specific Defects in T, B, and NK Cells and Age-Dependent Development of High IgE in Mice Heterozygous for a CADINS-Associated Dominant Negative CARD11 Allele.

Shelby M Hutcherson1, Jacquelyn R Bedsaul1, Joel L Pomerantz2.   

Abstract

CARD11 is a multidomain scaffold protein required for normal activation of NF-κB, JNK, and mTOR during Ag receptor signaling. Germline CARD11 mutations cause at least three types of primary immunodeficiency including CARD11 deficiency, B cell expansion with NF-κB and T cell anergy (BENTA), and CARD11-associated atopy with dominant interference of NF-κB signaling (CADINS). CADINS is uniquely caused by heterozygous loss-of-function CARD11 alleles that act as dominant negatives. CADINS patients present with frequent respiratory and skin infections, asthma, allergies, and atopic dermatitis. However, precisely how a heterozygous dominant negative CARD11 allele leads to the development of this CADINS-specific cluster of symptoms remains poorly understood. To address this, we generated mice expressing the CARD11 R30W allele originally identified in patients. We find that CARD11R30W/+ mice exhibit impaired signaling downstream of CARD11 that leads to defects in T, B, and NK cell function and immunodeficiency. CARD11R30W/+ mice develop elevated serum IgE levels with 50% penetrance that becomes more pronounced with age, but do not develop spontaneous atopic dermatitis. CARD11R30W/+ mice display reduced regulatory T cell numbers, but not the Th2 expansion observed in other mice with diminished CARD11 activity. Interestingly, the presence of mixed CARD11 oligomers in CARD11R30W/+ mice causes more severe signaling defects in T cells than in B cells, and specifically impacts IFN-γ production by NK cells, but not NK cell cytotoxicity. Our findings help explain the high susceptibility of CADINS patients to infection and suggest that the development of high serum IgE is not sufficient to induce overt atopic symptoms.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34341167      PMCID: PMC8355193          DOI: 10.4049/jimmunol.2001233

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  58 in total

1.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

Review 2.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

3.  Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.

Authors:  Reiko Matsumoto; Donghai Wang; Marzenna Blonska; Hongxiu Li; Masayuki Kobayashi; Bhanu Pappu; Yuhong Chen; Demin Wang; Xin Lin
Journal:  Immunity       Date:  2005-12       Impact factor: 31.745

4.  Dominant negative CARD11 mutations: Beyond atopy.

Authors:  Vivien Béziat; Emmanuelle Jouanguy; Anne Puel
Journal:  J Allergy Clin Immunol       Date:  2019-01-17       Impact factor: 10.793

5.  A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903.

Authors:  Verena Moosbrugger-Martinz; Matthias Schmuth; Sandrine Dubrac
Journal:  Methods Mol Biol       Date:  2017

6.  Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.

Authors:  Mako Nakaya; Yichuan Xiao; Xiaofei Zhou; Jae-Hoon Chang; Mikyoung Chang; Xuhong Cheng; Marzenna Blonska; Xin Lin; Shao-Cong Sun
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

7.  The MAGUK family protein CARD11 is essential for lymphocyte activation.

Authors:  Hiromitsu Hara; Teiji Wada; Chris Bakal; Ivona Kozieradzki; Shinobu Suzuki; Nobutaka Suzuki; Mai Nghiem; Emily K Griffiths; Connie Krawczyk; Birgit Bauer; Fulvio D'Acquisto; Sankar Ghosh; Wen Chen Yeh; Gottfried Baier; Robert Rottapel; Josef M Penninger
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

8.  Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.

Authors:  Henry Y Lu; Mehul Sharma; Ashish A Sharma; Atilano Lacson; Ashley Szpurko; Joanne Luider; Poonam Dharmani-Khan; Afshin Shameli; Peter A Bell; Gregory M T Guilcher; Victor A Lewis; Marta Rojas Vasquez; Sunil Desai; Lyle McGonigle; Luis Murguia-Favela; Nicola A M Wright; Consolato Sergi; Eytan Wine; Christopher M Overall; Sneha Suresh; Stuart E Turvey
Journal:  J Allergy Clin Immunol       Date:  2021-04-17       Impact factor: 10.793

9.  Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.

Authors:  Andrew L Snow; Wenming Xiao; Jeffrey R Stinson; Wei Lu; Benjamin Chaigne-Delalande; Lixin Zheng; Stefania Pittaluga; Helen F Matthews; Roland Schmitz; Sameer Jhavar; Stefan Kuchen; Lela Kardava; Wei Wang; Ian T Lamborn; Huie Jing; Mark Raffeld; Susan Moir; Thomas A Fleisher; Louis M Staudt; Helen C Su; Michael J Lenardo
Journal:  J Exp Med       Date:  2012-11-05       Impact factor: 14.307

10.  Marginal-Zone B-Cells Are Main Producers of IgM in Humans, and Are Reduced in Patients With Autoimmune Vasculitis.

Authors:  Daniel Appelgren; Per Eriksson; Jan Ernerudh; Mårten Segelmark
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

View more
  3 in total

1.  SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome.

Authors:  Darja Kanduc
Journal:  Glob Med Genet       Date:  2022-07-14

Review 2.  CARD11 signaling in regulatory T cell development and function.

Authors:  Nicole M Carter; Joel L Pomerantz
Journal:  Adv Biol Regul       Date:  2022-02-26

3.  Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.

Authors:  Jacquelyn R Bedsaul; Neha Shah; Shelby M Hutcherson; Joel L Pomerantz
Journal:  iScience       Date:  2022-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.